A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin)

Clinical trial NCT00336323 · COMPLETED

Trial details

NCT number: NCT00336323
Sponsor: Jaeb Center for Health Research
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetic Retinopathy

Start date: 2006-06-01
Primary completion: 2006-11-01
Enrollment: 121

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.